Cas:25110-79-6 1-methyl-5-pyridin-3-ylpyrrolidin-2-ol manufacturer & supplier

We serve Chemical Name:1-methyl-5-pyridin-3-ylpyrrolidin-2-ol CAS:25110-79-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-methyl-5-pyridin-3-ylpyrrolidin-2-ol

Chemical Name:1-methyl-5-pyridin-3-ylpyrrolidin-2-ol
CAS.NO:25110-79-6
Synonyms:5′-hydroxy-nicotine;1-METHYL-5-(3-PYRIDYL)-2-PYRROLIDINOL
Molecular Formula:C10H14N2O
Molecular Weight:178.23100
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:300.6ºC at 760 mmHg
Density:1.156g/cm3
Index of Refraction:1.573
PSA:36.36000
Exact Mass:178.11100
LogP:1.10460

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5′-hydroxy-nicotine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-METHYL-5-(3-PYRIDYL)-2-PYRROLIDINOL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-METHYL-5-(3-PYRIDYL)-2-PYRROLIDINOL Use and application,5′-hydroxy-nicotine technical grade,usp/ep/jp grade.


Related News: After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API. 1-methyl-5-pyridin-3-ylpyrrolidin-2-ol manufacturer We partner with life science companies of all sizes, drawing on over 20 years of industry experience. 1-methyl-5-pyridin-3-ylpyrrolidin-2-ol supplier According to the 2013-2018 New Drug Review Summary report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years. 1-methyl-5-pyridin-3-ylpyrrolidin-2-ol vendor The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 1-methyl-5-pyridin-3-ylpyrrolidin-2-ol factory The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population.